Track RMD's AI-powered predictions, market trends, and investment insights.
StockTwits Mentions
2
RMD has been mentioned an estimated 2 times on StockTwits over the last 24 hours.
Reddit Mentions
0
RMD has been mentioned an estimated 0 times on Reddit over the last 24 hours.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get StartedWith EPS at 10.37 and a PE ratio of 18.55, ResMed appears reasonably valued relative to its earnings power, suggesting solid underlying profitability. The valuation multiple is not stretched for a profitable, established med‑tech name, implying the market is pricing in moderate but sustainable growth rather than aggressive expectations. Overall, the earnings profile and multiple support a constructive view on fundamentals despite recent share price weakness.
The stock at $192.39 trades materially below its 200‑day moving average of $244.72, signaling a clear intermediate‑term downtrend. A 4.7% decline over the last month reinforces negative momentum, and trading this far under the 200‑day average typically reflects ongoing technical pressure. While the valuation is not demanding, the current technical setup leans bearish in the near to medium term.
Alternative data for ResMed presents a mixed but generally stable picture: web traffic is sizable, and social media followings are mostly growing modestly, while job openings have declined 16.6% month over month. The reduction in job postings could signal a more cautious hiring stance or efficiency focus, whereas steady to rising social audiences suggest ongoing brand engagement. Overall, these signals neither strongly reinforce the bearish technicals nor fully offset them, pointing to a neutral read‑through.
ResMed’s fundamentals, as implied by its earnings and valuation, look solid and reasonably priced, but the stock is in a clear technical downtrend, trading well below its 200‑day moving average with recent negative momentum. Alternative data are mixed: hiring has slowed, yet digital and social engagement remain broadly stable to positive. Taken together, the setup appears neutral overall—fundamentals offer support, but technical weakness and cautious hiring temper a fully bullish stance.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
You don't hold RMD in your mock portfolio yet.
RMD social sentiment across Reddit and StockTwits totals 101 mentions over the past seven days, with StockTwits accounting for the overwhelming majority at 95 mentions versus just 6 on Reddit. This imbalance suggests that short-term traders and swing players are driving most of the conversation, while longer-form retail investor discussion remains limited. The activity comes as ResMed shares declined 2.2% in the latest session to $186.44, a move that may be drawing reactive commentary rather than proactive conviction from the social trading community.
The gap between StockTwits and Reddit engagement is a meaningful signal in itself. StockTwits activity at 95 mentions reflects a trader-oriented audience focused on near-term price action, particularly relevant given the 2.2% single-day drop. Reddit's 6 mentions indicate minimal traction in longer-horizon retail communities, suggesting RMD is not currently a high-conviction name among fundamentals-focused investors. Where StockTwits sentiment may lean reactively bearish following the price decline, Reddit's near-silence offers no meaningful counter-narrative. Combined, the data points to low social conviction for RMD at current levels.
TrendEdge integrates Reddit and StockTwits sentiment as one component within its broader AI scoring model. For RMD, that model currently assigns a score of 6 out of 10, reflecting a balanced but cautious outlook. Social sentiment data is weighted alongside technical indicators, institutional flow signals, and alternative data sources to provide a more complete picture than any single input alone. This multi-signal approach reduces the noise inherent in social media and surfaces sentiment trends that are more likely to carry predictive value.
Unlock comprehensive alternative data signals to make better investment decisions
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Web Traffic
2,881,283
Twitter Followers
10,881
Instagram Followers
17,276
YouTube Subscribers
60,100
LinkedIn Followers
259,529
Job Postings
270
LinkedIn Employees
9,016
News Mentions
0
Key Metrics
